Literature DB >> 2715571

Toxicokinetics of ochratoxin A in several species and its plasma-binding properties.

S Hagelberg1, K Hult, R Fuchs.   

Abstract

The toxicokinetic profile of ochratoxin A was studied after the oral or intravenous administration of 50 ng/g b.w. to fish, quail, mouse, rat and monkey. The elimination half-life varied from 0.68 h after oral administration to fish, up to 840 h after intravenous administration to monkey. The distribution volume ranged from 57 ml/kg in fish to 1500 ml/kg in quail. The plasma clearance was most rapid in quail and fish, 72 and 58 ml/kg.h, respectively, while it was only 0.17 ml/kg.h in monkey. The bioavailability was as low as 1.6% in fish but as high as 97% in mouse. The binding abilities of ochratoxin A to plasma proteins were also studied. From these data we calculated the free fraction of toxin in plasma, which we found to be less than 0.2% in all species investigated (including man) except fish. A similar but smaller investigation on the toxicokinetics and binding properties of ochratoxin B was also performed. Ochratoxin B was more readily eliminated and had a lower affinity for plasma proteins, which partly may explain its lower toxicity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2715571     DOI: 10.1002/jat.2550090204

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  43 in total

1.  A risk assessment of dietary Ochratoxin a in the United States.

Authors:  Nicole J Mitchell; Chen Chen; Jeffrey D Palumbo; Andreia Bianchini; Jack Cappozzo; Jayne Stratton; Dojin Ryu; Felicia Wu
Journal:  Food Chem Toxicol       Date:  2016-12-30       Impact factor: 6.023

2.  Metabolism and toxicokinetics of the mycotoxin ochratoxin A in F344 rats.

Authors:  H Zepnik; W Völkel; W Dekant
Journal:  Mycotoxin Res       Date:  2003-06       Impact factor: 3.833

3.  The dialysis of Ochratoxin A (OTA).

Authors:  F Malir; J Severa; T Roubal; J Kacerovsky; P Fixa; P Moucka; J Zahradnik; J Knizek; J Osterreicher; M Brndiar; M Cerna
Journal:  Mycotoxin Res       Date:  2001-06       Impact factor: 3.833

4.  A reproductive and developmental screening study of the fungal toxin ochratoxin A in Fischer rats.

Authors:  Genevieve S Bondy; Laurie Coady; Nikia Ross; Don Caldwell; Anne Marie Gannon; Keri Kwong; Stephen Hayward; David E Lefebvre; Virginia Liston; Jayadev Raju; Peter Pantazopoulos; Ivan Curran
Journal:  Mycotoxin Res       Date:  2018-07-04       Impact factor: 3.833

5.  The myocotoxin ochratoxin A is a substrate for phenylalanine hydroxylase in isolated rat hepatocytes and in vivo.

Authors:  E E Creppy; K Chakor; M J Fisher; G Dirheimer
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

6.  Why mammals more susceptible to the hepatotoxic microcystins than fish: evidences from plasma and albumin protein binding through equilibrium dialysis.

Authors:  Wei Zhang; Gaodao Liang; Laiyan Wu; Xun Tuo; Wenjing Wang; Jun Chen; Ping Xie
Journal:  Ecotoxicology       Date:  2013-05-23       Impact factor: 2.823

7.  Ochratoxin A in human blood serum - retrospective long-term data.

Authors:  Erwin Märtlbauer; Ewald Usleber; Richard Dietrich; Elisabeth Schneider
Journal:  Mycotoxin Res       Date:  2009-09-15       Impact factor: 3.833

Review 8.  Ochratoxin A and human health risk: a review of the evidence.

Authors:  Travis R Bui-Klimke; Felicia Wu
Journal:  Crit Rev Food Sci Nutr       Date:  2015       Impact factor: 11.176

9.  Foodstuffs and human blood contamination by the mycotoxin ochratoxin A: correlation with chronic interstitial nephropathy in Tunisia.

Authors:  K Maaroufi; A Achour; A M Betbeder; M Hammami; F Ellouz; E E Creppy; H Bacha
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

10.  Survey of slaughtered pigs for occurrence of ochratoxin A and porcine nephropathy in Serbia.

Authors:  Dragan Milićević; Verica Jurić; Srđan Stefanović; Milijan Jovanović; Saša Janković
Journal:  Int J Mol Sci       Date:  2008-11-07       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.